Skip to main content

Advertisement

SpringerLink
Log in

Reflux esophagitis, high-grade neoplasia, and early Barrett’s carcinoma—what is the place of the Merendino procedure?

  • Overview
  • Published:
Langenbeck's Archives of Surgery Aims and scope Submit manuscript

Abstract

Introduction

Because of the increasing frequency of Barrett’s cancer in Western industrialized countries, the management of reflux disease with the potential development of Barrett’s esophagus, neoplasia, and early carcinoma is very important. In case of established Barrett’s esophagus, the malignant degeneration of the specialized epithelium cannot definitely be prevented by antireflux surgery or continuous medication. Mucosal adenocarcinomas nearly never develop lymph node metastasis and can mostly be treated by endoscopic mucosectomy. The deeper the submucosa is infiltrated, the higher is the rate of lymph node metastasis which is, on the average, 30% for submucosal carcinoma.

Conclusions

Therefore, radical subtotal esophagectomy is the treatment of choice for submucosal carcinoma, whereas distal esophageal resection with limited lymph node dissection is only indicated in mucosal carcinoma which cannot be completely removed by interventional endoscopy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Bollschweiler E, Knoppe K, Wolfgarten E, Hölscher AH (2007) Prevalence of reflux symptoms in the Cologne normal population. Z Gastroenterol 45:177–181 doi:10.1055/s-2006-927402

    Article  PubMed  CAS  Google Scholar 

  2. Forgacs I, Loganayagam A (2008) Overprescribing proton pump inhibitors. BMJ 336:2–3 doi:10.1136/bmj.39406.449456.BE

    Article  PubMed  Google Scholar 

  3. Hölscher AH, Bollschweiler E, Gutschow C (2007) GERD and complications: when is surgery necessary? Z Gastroenterol 45:1150–1155 doi:10.1055/s-2007-963630

    Article  PubMed  Google Scholar 

  4. Froelicher P, Miller G (1986) The European experience with esophageal cancer limited to the mucosa and submucosa. Gastrointest Endosc 32:88–90 (95–9)

    Article  PubMed  CAS  Google Scholar 

  5. Bollschweiler E, Wolfgarten E, Gutschow C, Hölscher AH (2001) Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer 92:549–555 doi:10.1002/1097-0142(20010801)92:3<549::AID-CNCR1354>3.0.CO;2-L

    Article  PubMed  CAS  Google Scholar 

  6. Parfitt JR, Miladinovic Z, Driman DK (2006) Increasing incidence of adenocarcinoma of the gastroesophageal junction and distal stomach in Canada—an epidemiological study from 1964 to 2002. Can J Gastroenterol 20:271–276

    PubMed  Google Scholar 

  7. Hölscher A, Bollschweiler E, Schneider P, Siewert J (1997) Early adenocarcinoma in Barrett’s oesophagus. Br J Surg 84:1470–1473 doi:10.1002/bjs.1800841035

    Article  PubMed  Google Scholar 

  8. Bollschweiler E, Baldus S, Schroeder W, Prenzel K, Gutschow C, Schneider P, Hölscher A (2006) High rate of lymph-node metastasis in submucosal esophageal squamous-cell carcinomas and adenocarcinomas. Endoscopy 38:149–156 doi:10.1055/s-2006-924993

    Article  PubMed  CAS  Google Scholar 

  9. Spechler SJ (2002) Clinical practice. Barrett’s Esophagus. N Engl J Med 346:836–842 doi:10.1056/NEJMcp012118

    Article  PubMed  Google Scholar 

  10. Jankowski JA, Provenzale D, Moayyedi P (2002) Esophageal adenocarcinoma arising from Barrett’s metaplasia has regional variations in the west. Gastroenterology 122:588–590 doi:10.1053/gast.2002.31599

    Article  PubMed  Google Scholar 

  11. Solaymani-Dodaran M, Logan RF, West J et al (2004) Risk of oesophageal cancer in Barrett’s oesophagus and gastro-oesophageal reflux. Gut 53:1070–1074 doi:10.1136/gut.2003.028076

    Article  PubMed  CAS  Google Scholar 

  12. Hage M, Siersema PD, van Dekken H et al (2004) Oesophageal cancer incidence and mortality in patients with long-segment Barrett’s oesophagus after a mean follow-up of 12.7 years. Scand J Gastroenterol 39:1175–1179 doi:10.1080/00365520410003524

    Article  PubMed  CAS  Google Scholar 

  13. Voutilainen M, Sipponen P, Mecklin JP, Juhola M, Farkkila M (2000) Gastroesophageal reflux disease: prevalence, clinical, endoscopic and histopathological findings in 1,128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms. Digestion 61:6–13 doi:10.1159/000007730

    Article  PubMed  CAS  Google Scholar 

  14. Malfertheiner P, Lind T, Willich S, Vieth M, Jaspersen D, Labenz J, Meyer-Sabellek W, Junghard O, Stolte M (2005) Prognostic influence of Barrett’s esophagus and Helicobacter pylori infection on healing of ertosive gastroesophageal (GORD) and symptom resolution in non-erosive GORD: report from the ProGORD Study. Gut 54:746–751 doi:10.1136/gut.2004.042143

    Article  PubMed  CAS  Google Scholar 

  15. van Soest E, Dieleman J, Siersema P, Sturkenboom M, Kuipers E (2005) Increasing incidence of Barrett’s oesophagus in the general population. Gut 54:1062–1066 doi:10.1136/gut.2004.063685

    Article  PubMed  Google Scholar 

  16. Dent J, El-Serag H, Wallander M, Johansson S (2005) Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 54:710–717 doi:10.1136/gut.2004.051821

    Article  PubMed  CAS  Google Scholar 

  17. Bardhan KD, Royston C, Nayyar AK (2006) Reflux rising! An essay on witnessing a disease in evolution. Dig Liver Dis 38:163–168 doi:10.1016/j.dld.2005.10.011

    Article  PubMed  CAS  Google Scholar 

  18. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57–70 doi:10.1016/S0092-8674(00)81683-9

    Article  PubMed  CAS  Google Scholar 

  19. Morales CP, Souza RF, Spechler SJ (2002) Hallmarks of cancer progression in Barrett’s oesophagus. Lancet 360:1587–1589 doi:10.1016/S0140-6736(02)11569-8

    Article  PubMed  Google Scholar 

  20. Whittles CE, Biddlestone LR, Burton A, Barr H, Jankowski JA, Warner PJ, Shepherd NA (1999) Apoptotic and proliferative activity in the neoplastic progression of Barrett’s oesophagus: a comparative study. J Pathol 187:535–540 doi:10.1002/(SICI)1096-9896(199904)187:5<535::AID-PATH302>3.0.CO;2-G

    Article  PubMed  CAS  Google Scholar 

  21. Klump B, Hsieh CJ, Holzmann K, Gregor M, Porschen R (1998) Hypermethylation of the CDKN2/p16 promoter during neoplastic progression in Barrett’s esophagus. Gastroenterology 115:1381–1386 doi:10.1016/S0016-5085(98)70016-2

    Article  PubMed  CAS  Google Scholar 

  22. Vallböhmer D, Peters JH, Oh D, Kuramochi H, Shimizu D, Demeester SR, Hagen JA, Chandrasoma PT, Danenberg KD, DeMeester TR, Danenberg P (2005) Survivin, a potential biomarker in the development of Barrett’s adenocarcinoma. Surgery 138:701–706 doi:10.1016/j.surg.2005.06.051

    Article  PubMed  Google Scholar 

  23. Morales CP, Lee EL, Shay JW (1998) In situ hybridization for the detection of telomerase RNA in the progression from Barrett’s esophagus to esophageal adenocarcinoma. Cancer 83:652–659 doi:10.1002/(SICI)1097-0142(19980815)83:4<652::AID-CNCR4>3.0.CO;2-M

    Article  PubMed  CAS  Google Scholar 

  24. Vallböhmer D, Peters JH, Kuramochi H, Oh D, Yang D, Shimizu D, DeMeester SR, Hagen JA, Chandrasoma PT, Danenberg KD, Danenberg PV, DeMeester TR (2006) Molecular determinants in targeted therapy for esophageal adenocarcinoma. Arch Surg 141:476–481 doi:10.1001/archsurg.141.5.476

    Article  PubMed  Google Scholar 

  25. Salmela MT, Karjalainen-Lindsberg ML, Puolakkainen P, Saarialho-Kere U (2001) Upregulation and differential expression of matrilysin (MMP-7) and metalloelastase (MMP-12) and their inhibitors TIMP-1 and TIMP-3 in Barrett’s oesophageal adenocarcinoma. Br J Cancer 85:383–392 doi:10.1054/bjoc.2001.1929

    Article  PubMed  CAS  Google Scholar 

  26. Schlemper R, Riddell R, Kato Y, Borchard F, Cooper H, Dawsey S, Dixon M, Fenoglio-Preiser C, Flejou J, Geboes K, Hattori T, Hirota T, Irabashi M, Iwafuchi M, Iwashita A, Kim Y, Kirchner T, Klimpfinger M, Koike M, Lauwers G, Lewin K, Oberhuber G, Offner F, Price A, Rubio C, Shimizu M, Shimoda T, Sipponen P, Solcia E, Stolte M, Watanabe H, Yamabe H (2000) The Vienna classification of gastrointestinal epithelial neoplasia. Gut 47:251–255 doi:10.1136/gut.47.2.251

    Article  PubMed  CAS  Google Scholar 

  27. Dixon M (2002) Gastrointestinal epithelial neoplasia: Vienna revisited. Gut 51:130–131 doi:10.1136/gut.51.1.130

    Article  PubMed  CAS  Google Scholar 

  28. Rugge M, Cassaro M, Di MF, Leo G, Russo V, Pennelli G, Farinati F (2003) The long term outcome of gastric non-invasive neoplasia. Gut 52:1111–1116 doi:10.1136/gut.52.8.1111

    Article  PubMed  CAS  Google Scholar 

  29. Tsukuma H, Oshima O, Narahara H, Morii T (2000) Natural history of early gastric cancer: a non-concurrent, long-term follow up study. Gut 47:618–621 doi:10.1136/gut.47.5.618

    Article  PubMed  CAS  Google Scholar 

  30. Gutschow C, Schröder W, Prenzel K, Bollschweiler E, Romagnoli R, Collard J, Hölscher A (2002) Impact of antireflux surgery on Barrett’s esophagus. Langenbecks Arch Surg 387:138–145 doi:10.1007/s00423-002-0303-0

    Article  PubMed  Google Scholar 

  31. Chang E, Morris C, Seltman A, O’Rourke R, Chan B, Hunter J, Jobe B (2007) The effect of antireflux surgery on esophageal carcinogenesis in patients with barrett esophagus: a systematic reviwe. Ann Surg 246:11–21 doi:10.1097/01.sla.0000261459.10565.e9

    Article  PubMed  Google Scholar 

  32. Parrilla P, Martinez dHL, Ortiz A, Munitiz V, Molina J, Bermejo J, Canteras M (2003) Long term results of a randomized prospective study comparing medical and surgical treatment of Barret’s esophagus. Ann Surg 237:291–298 doi:10.1097/00000658-200303000-00001

    Article  PubMed  Google Scholar 

  33. Rossi M, Barreca M, de Bortoli N, Renzi C, Santi S, Gennai A, Bellini M, Costa F, Conio M, Marchi S (2006) Efficacy of Nissen fundoplication versus medical therapy in the regression of low-grade dysplasia in patients with Barrett esophagus: a prospective study. Ann Surg 243:58–63 doi:10.1097/01.sla.0000194085.56699.db

    Article  PubMed  Google Scholar 

  34. Liu L, Hofstetter W, Rashid A et al (2005) Significance of the depth of tumor invasion in early (T1) esophageal adenocarcinoma. Mod Pathol 18:110A–110A

    Google Scholar 

  35. Westerterp M, Koppert L, Buskens C et al (2005) Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction. Virchows Arch 446:497–504 doi:10.1007/s00428-005-1243-1

    Article  PubMed  Google Scholar 

  36. May A, Gunter E, Roth F, Gossner L, Stolte M, Vieth M et al (2004) Accuracy of staging in early oesophageal cancer using high resolution endoscopy and high resolution endosonography: a comparative, prospective, and blinded trial. Gut 53:634–640 doi:10.1136/gut.2003.029421

    Article  PubMed  CAS  Google Scholar 

  37. Rice T (1999) Superficial oesophagueal carcinoma: is there a need for three-field lymphadenectomy? Lancet 354:792–794

    PubMed  CAS  Google Scholar 

  38. Shimada H, Nabeya Y, Matsubara H et al (2006) Prediction of lymph node status in patients with superficial esophageal carcinoma: analysis of 160 surgically resected cancers. Am J Surg 191:250–254 doi:10.1016/j.amjsurg.2005.07.035

    Article  PubMed  Google Scholar 

  39. Araki K, Ohno S, Egashira A, Saeki H, Kawaguchi H, Sugimachi K (2002) Pathologic features of superficial esohageal squamous cell carcinoma with lymph node and distal metastasis. Cancer 94:570–575 doi:10.1002/cncr.10190

    Article  PubMed  Google Scholar 

  40. Endo M, Yoshino K, Kawano T, Nagai K, Inoue H (2000) Clinocopathologic analysis of lymph node metastasis in surgically resected superficial cancer of the thoracic esophagus. Dis Esophagus 13:125–129 doi:10.1046/j.1442-2050.2000.00100.x

    Article  PubMed  CAS  Google Scholar 

  41. Chibana Y, Fujii S, Ichikawa K, Fujita M, Ono Y, Tomita S, Imura J, Kawamata H, Terano A, Fujimori T (2005) Tumor cell dissociation score highly correlates with lymph node metastasis in superficial esophageal carcinoma. J Gastroenterol Hepatol 20:1371–1378 doi:10.1111/j.1440-1746.2005.03858.x

    Article  PubMed  Google Scholar 

  42. Sato Y, Motoyama S, Maruyama K, Okuyama M, Ogawa J (2005) A second malignancy is the major cause of death among thoracic squamous cell esophageal cancer patients negative for lymph node involvement. J Am Coll Surg 201:188–193 doi:10.1016/j.jamcollsurg.2005.03.013

    Article  PubMed  Google Scholar 

  43. van Sandick J, van Lanschot J, ten Kate F, Offerhaus G, Fockens P, Tytgat G et al (2000) Pathology of early invasive adenocarcinoma of the esophagus or esophagogastric junction: implications for therapeutic decision making. Cancer 88:2429–2437 doi:10.1002/1097-0142(20000601)88:11<2429::AID-CNCR1>3.0.CO;2-H

    Article  PubMed  Google Scholar 

  44. Hagen J, De Meester S, Peters J et al (2001) Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies. Ann Surg 234:520–530 doi:10.1097/00000658-200110000-00011

    Article  PubMed  CAS  Google Scholar 

  45. Rice T, Blackstone E, Goldblum J et al (2001) Superficial adenocarcinoma of the esophagus. J Thorac Cardiovasc Surg 122:1077–1090 doi:10.1067/mtc.2001.113749

    Article  PubMed  CAS  Google Scholar 

  46. Stein H, Feith M, von_Rahden B et al (2003) Approach to early Barrett’s cancer. World J Surg 27:1040–1046 doi:10.1007/s00268-003-7059-8

    Article  PubMed  Google Scholar 

  47. Oh DS, Hagen JA, T Chandrasoma P et al (2006) Clinical biology and surgical therapy of intramucosal adenocarcinoma of the esophagus. J Am Coll Surg 203:152–161 doi:10.1016/j.jamcollsurg.2006.05.006

    Article  PubMed  Google Scholar 

  48. May A, Gossner L, Behrens A, Kohnen R, Vieth M, Stolte M, Ell C (2003) A prospective randomized trial of two different endoscopic resection techniques for early stage cancer of the esophagus. Gastrointest Endosc 58:167–175 doi:10.1067/mge.2003.339

    Article  PubMed  Google Scholar 

  49. Ell C, May A, Gossner L, Pech O, Gunter M, Mayer G, Henrich R, Vieth M, Muller H, Seitz G, Stolte M (2000) Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett’s esophagus. Gastroenterology 118:670–677 doi:10.1016/S0016-5085(00)70136-3

    Article  PubMed  CAS  Google Scholar 

  50. Ell C, May A, Pech O, Gossner L, Gunter E, Behrens A, Nachbar L, Huijsmans J, Vieth M, Stolte M (2007) Curative endoscopic resection of early esophageal adenocarcinomas (Barrett’s cancer). Gastrointest Endosc 65:3 doi:10.1016/j.gie.2006.04.033

    Article  PubMed  Google Scholar 

  51. Overholt BF, Banjepouhr M, Halberg DL (2003) Photodynamic therapy for Barrett’s esophagus with dysplasia and/or early stage carcinoma: long-term results. Gastrointest Endosc 58:183–188 doi:10.1067/mge.2003.327

    Article  PubMed  Google Scholar 

  52. Merendino KA, Dilard DH (1955) The concept of sphincter substitution by an interposed jejunal segment for anatomic and physiologic abnormalities at the esophagogastric junction. Ann Surg 142:486–509

    Article  PubMed  CAS  Google Scholar 

  53. Gutschow C, Schroder W, Wolfgarten E, Holscher A (2004) Merendino procedure with preservation of the vagus for early carcinoma of the gastroesophageal junction. Zentralbl Chir 129:276–281 doi:10.1055/s-2004-820307

    Article  PubMed  CAS  Google Scholar 

  54. Stein H, Feith M, Mueller J et al (2000) Limited resection for early adenocarcinoma in Barrett’s esophagus. Ann Surg 232:733–742 doi:10.1097/00000658-200012000-00002

    Article  PubMed  CAS  Google Scholar 

  55. Banki F, Mason RJ, DeMeester SR, Hagen JA, Balaji NS, Crookes PF, Bremner CG, Peters JH, DeMeester TR (2002) Vagal-sparing esophagectomy: a more physiologic alternative. Ann Surg 236:324–336 doi:10.1097/00000658-200209000-00009

    Article  PubMed  Google Scholar 

  56. Peyre C, Demeester S, Rizzetto C, Bansal N, Tang A, Ayazi S, Leers J, Lipham J, Hagen J, Demeester T (2007) Vagal-sparing esophagectomy: the ideal operation for intramucosal adenocarcinoma and Barrett with high-grade dysplasia. Ann Surg 246:665–674 doi:10.1097/SLA.0b013e318155a7a1

    Article  PubMed  Google Scholar 

  57. Hulscher J, van Sandick J, de Boer A et al (2002) Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 347:1662–1669 doi:10.1056/NEJMoa022343

    Article  PubMed  Google Scholar 

  58. van Sandick J, van Lanschot J, ten Kate F et al (2002) Indicators of prognosis after transhiatal esophageal resection without thoracotomy for cancer. J Am Coll Surg 194:28–36 doi:10.1016/S1072-7515(01)01119-X

    Article  PubMed  Google Scholar 

  59. Hölscher AH (2007) Endoscopic mucosal resection for early squamous cell cancer of the esophagus—a dangerous game or standard treatment. Endoscopy 39:1–3 doi:10.1055/s-2007-966175

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of General, Visceral and Cancer Surgery, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany

    A. H. Hölscher, D. Vallböhmer, C. Gutschow & E. Bollschweiler

Authors
  1. A. H. Hölscher
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. Vallböhmer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Gutschow
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E. Bollschweiler
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. H. Hölscher.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hölscher, A.H., Vallböhmer, D., Gutschow, C. et al. Reflux esophagitis, high-grade neoplasia, and early Barrett’s carcinoma—what is the place of the Merendino procedure?. Langenbecks Arch Surg 394, 417–424 (2009). https://doi.org/10.1007/s00423-008-0429-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00423-008-0429-9

Keywords

Search

Navigation